Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?

Araz, MİNE; Soydal, ÇİĞDEM; Gündüz, PINAR; Kırmızı, BİLGE; Bakırarar, BATUHAN; Sak, SERPİL; Özkan, ELGİN

doi:10.4274/mirt.galenos.2022.59140

Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?

Araz M., Soydal Ç., Gündüz P., Kırmızı B. A., Bakırarar B., Sak S., ...Daha Fazla

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.31, sa.1, ss.49-56, 2022 (ESCI, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 31 Sayı: 1
Basım Tarihi: 2022
Doi Numarası: 10.4274/mirt.galenos.2022.59140
Dergi Adı: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.49-56
Anahtar Kelimeler: Breast cancer, PET/CT, fluorodeoxyglucose, hormone receptor, CANCER, ESTROGEN, FEATURES, VOLUME, SUV
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Ankara Üniversitesi Adresli: Evet

Özet

Objectives: This study aimed to investigate the role of preoperative 'fluorine-fluorodeoxyglucose (F-18-FDG) positron emission tomography/ computed tomography (PET/CT) radiomics features and metabolic parameters of primary breast tumors in predicting hormone receptor (HR) positivity.